Angiotensin Converting Enzyme Ace Inhibitors Market Size And Share

Report Code : TIPRE00020853
Category : Life Sciences

No. of Pages : 150

Buy Now

Marktgröße und Marktanteil von Angiotensin-Converting-Enzyme (ACE)-Hemmern bis 2025 – 2031

Buy Now

Angiotensin Converting Enzyme (ACE) Inhibitors Market Report Analysis

Angiotensin Converting Enzyme (ACE) Inhibitors Market

CAGR (2023 - 2031)
XX%
Market Size 2023
US$ XX million
Market Size 2031
US$ XX Million

Report Coverage

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis

Industry landscape and competition analysis & recent developments
Detailed company profiles

Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

Novartis AG
Pfizer, Inc
Merck & Co., Inc.
Bristol Myers Squibb
Astra and Zeneca
UCB (Schwarz Pharma Inc.)
Solvay Pharmaceuticals B.V.
Abbott
Endo International (Par Pharmaceutical, Inc.)

Regional Overview

Nordamerika
Europa
Asien-Pazifik
Süd- und Mittelamerika
Naher Osten und Afrika

Market Segmentation

By Produkt

Benazepril
Captopril
Enalapril
Fosinopril
Lisinopril
andere

By Indikation

Herz-Kreislauf-Erkrankungen
Bluthochdruck
chronische Nierenerkrankungen
Diabetes
Sklerodermie
Migräne

By Vertriebskanal

Online-Apotheken
Einzelhandels- und Krankenhausapotheken

By Geographie

Nordamerika
Europa
Asien-Pazifik
Süd- und Mittelamerika